AGE
Price:
$11.1
Market Cap:
$27.76M
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation...[Read more]
Industry
Biotechnology
IPO Date
2018-11-29
Stock Exchange
AMEX
Ticker
AGE
According to AgeX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -98.53% compared to the average of -1.56 of the last 4 quarters.
The mean historical PE Ratio of AgeX Therapeutics, Inc. over the last ten years is -6.62. The current -0.02 PE Ratio has changed -65.26% with respect to the historical average. Over the past ten years (40 quarters), AGE's PE Ratio was at its highest in in the March 2024 quarter at -0.82. The PE Ratio was at its lowest in in the March 2018 quarter at -103.75.
Average
-6.62
Median
-5.22
Minimum
-14.76
Maximum
-0.99
Discovering the peaks and valleys of AgeX Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.99
Minimum Annual Increase = -60.64%
Minimum Annual PE Ratio = -14.76
Year | PE Ratio | Change |
---|---|---|
2023 | -0.99 | -49.70% |
2022 | -1.96 | -51.45% |
2021 | -4.04 | -22.53% |
2020 | -5.22 | -4.76% |
2019 | -5.48 | -60.64% |
2018 | -13.92 | -5.70% |
The current PE Ratio of AgeX Therapeutics, Inc. (AGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.33
5-year avg
-3.54
10-year avg
-6.62
AgeX Therapeutics, Inc.’s PE Ratio is greater than MAIA Biotechnology, Inc. (-2.30), greater than Larimar Therapeutics, Inc. (-7.49), greater than Graphite Bio, Inc. (-0.13), greater than Lyra Therapeutics, Inc. (-0.17), greater than Lineage Cell Therapeutics, Inc. (-6.43), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.44), greater than ImmuCell Corporation (-6.92), greater than Oxford Nanopore Technologies plc (-4.44), less than Praxis Precision Medicines, Inc. (0), greater than Foghorn Therapeutics Inc. (-10.68), greater than Synaptogenix, Inc. (-4.90), greater than Invivyd, Inc. (-2.01), greater than Biohaven Pharmaceutical Holding Company Ltd. (-0.53), greater than Immunome, Inc. (-5.90), greater than Inhibrx Biosciences, Inc. (-2.89), less than Icosavax, Inc. (0.14), greater than null (-8.27),
Company | PE Ratio | Market cap |
---|---|---|
-2.30 | $69.68M | |
-7.49 | $484.93M | |
-0.13 | $185.19M | |
-0.17 | $16.95M | |
-6.43 | $155.64M | |
-2.44 | $15.23M | |
-6.92 | $28.12M | |
-4.44 | $1.70B | |
0 | $1.25B | |
-10.68 | $454.79M | |
-4.90 | $3.88M | |
-2.01 | $107.50M | |
-0.53 | $5.06B | |
-5.90 | $759.69M | |
-2.89 | $224.59M | |
0.14 | $769.04M | |
-8.27 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgeX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AgeX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AgeX Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for AgeX Therapeutics, Inc. (AGE)?
What is the highest PE Ratio for AgeX Therapeutics, Inc. (AGE)?
What is the 3-year average PE Ratio for AgeX Therapeutics, Inc. (AGE)?
What is the 5-year average PE Ratio for AgeX Therapeutics, Inc. (AGE)?
How does the current PE Ratio for AgeX Therapeutics, Inc. (AGE) compare to its historical average?